| Polymyxin and lipopeptide antibiotics: membrane-targeting drugs of last resort EVK Ledger, A Sabnis, AM Edwards Microbiology 168 (2), 001136, 2022 | 61 | 2022 |
| Human serum triggers antibiotic tolerance in Staphylococcus aureus EVK Ledger, S Mesnage, AM Edwards Nature Communications 13 (1), 2041, 2022 | 48 | 2022 |
| Antibiotic interceptors: creating safe spaces for bacteria A Sabnis, EVK Ledger, V Pader, AM Edwards PLoS pathogens 14 (4), e1006924, 2018 | 32 | 2018 |
| Enterococcus faecalis and pathogenic streptococci inactivate daptomycin by releasing phospholipids EVK Ledger, V Pader, AM Edwards Microbiology 163 (10), 1502-1508, 2017 | 24 | 2017 |
| A FASII inhibitor prevents staphylococcal evasion of daptomycin by inhibiting phospholipid decoy production CJE Pee, V Pader, EVK Ledger, AM Edwards Antimicrobial Agents and Chemotherapy 63 (4), 10.1128/aac. 02105-18, 2019 | 15 | 2019 |
| Growth arrest of Staphylococcus aureus induces daptomycin tolerance via cell wall remodelling EVK Ledger, AM Edwards Mbio 14 (1), e03558-22, 2023 | 4 | 2023 |
| Human serum induces daptomycin tolerance in Enterococcus faecalis and viridans group streptococci ARH Tickle, EVK Ledger, AM Edwards Microbiology 168 (12), 001282, 2022 | 4 | 2022 |
| XerC is required for the repair of antibiotic-and immune-mediated DNA damage in Staphylococcus aureus EVK Ledger, K Lau, EW Tate, AM Edwards Antimicrobial Agents and Chemotherapy 67 (3), e01206-22, 2023 | 3 | 2023 |
| Host-induced cell wall remodeling impairs opsonophagocytosis of Staphylococcus aureus by neutrophils EVK Ledger, AM Edwards mBio 15 (8), e01643-24, 2024 | | 2024 |
